Evidence map›Paper›PMID 35510608›Full record

ArticleJournal of diabetes2022

Kidney disease parameters, metabolic goal achievement, and arterial stiffness risk in Chinese adult people with type 2 diabetes.

Chen Xu, Li Li, Juan Shi, Bangqun Ji, Qidong Zheng, Yufan Wang, Tingyu Ke, Li Li, Dong Zhao, Yuancheng Dai and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Chen XuDepartment of Endocrinology and Metabolism, People's Hospital of Zhengzhou Affiliated Henan University of Chinese Medicine, Zhengzhou, China.
Li LiDepartment of Endocrinology and Metabolism, People's Hospital of Zhengzhou Affiliated Henan University of Chinese Medicine, Zhengzhou, China.
Juan ShiDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-2652-8084
Bangqun JiDepartment of Endocrinology, Xingyi People's Hospital, Xingyi, China.
Qidong ZhengDepartment of Internal medicine, The Second People's Hospital of Yuhuan, Yuhuan, China.
Yufan WangDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tingyu KeDepartment of Endocrinology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Li LiDepartment of Endocrinology, Ningbo First Hospital, Ningbo, China.
Dong ZhaoCenter for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0002-9847-5439
Yuancheng DaiDepartment of Internal medicine of traditional Chinese medicine, Sheyang Diabetes Hospital, Yancheng, China.
Fengmei XuDepartment of Endocrinology and Metabolism, Hebi Coal (Group), LTD, General Hospital, Hebi, China.
Ying PengDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-1069-7000
Yifei ZhangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-0272-0602
Qijuan DongDepartment of Endocrinology and Metabolism, People's Hospital of Zhengzhou Affiliated Henan University of Chinese Medicine, Zhengzhou, China.
Weiqing WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Jiao Tong University · CNFirst Affiliated Hospital of Henan University · CNAnyang Hospital of Traditional Chinese Medicine · CNBeijing Luhe Hospital Affiliated to Capital Medical University · CNHefei Design and Research Institute of Coal Industry (China) · CNKunming Medical University · CNYuxian People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate the arterial stiffness (AS) risk within urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) categories and the joint effect between kidney disease parameters and metabolic goal achievement on AS risk in adult people with type 2 diabetes (T2D).

methodsA total of 27 439 Chinese participants with T2D from 10 National Metabolic Management Centers (MMC) were categorized into four albuminuria/decreased eGFR groups. The criteria for decreased eGFR and AS were eGFR <90 ml/min/1.73 m

resultsAfter full adjustment, odds ratios (ORs) for AS were highest for albuminuria and decreased eGFR (2.23 [1.98-2.52]) and were higher for albuminuria and normal eGFR (1.52 [1.39-1.67]) than for those with nonalbuminuria and decreased eGFR (1.17 [1.04-1.32]). Both UACR and eGFR in the subgroup or overall population independently correlated with AS risk. The achievement of ≥2 metabolic goals counteracted the association between albuminuria and AS risk (OR: 0.93; 95% CI: 0.80-1.07; p = .311). When the metabolic goals added up to ≥2 for patients with decreased eGFR, they showed significantly lower AS risk (OR: 0.65; 95% CI: 0.56-0.74; p < .001).

conclusionsBoth higher UACR and lower eGFR are determinants of AS risk, with UACR more strongly related to AS than eGFR in adults with T2D. The correlation between albuminuria/decreased eGFR and AS was modified by the achievement of multiple metabolic elements.

Indexed as

Diabetes Mellitus, Type 2Kidney DiseasesVascular StiffnessAdultAlbuminuriaAnkle Brachial IndexChinaCreatinineGlomerular Filtration RateGoalsHumansPulse Wave AnalysisCreatinine2型糖尿病brachial-ankle pulse wave velocity (baPWV)cardiovascular disease (CVD)estimated glomerular filtration rate (eGFR)metabolic goaltype 2 diabetesurinary albumin-to-creatinine ratio (UACR)代谢目标估计肾小球滤过率(eGFR)尿白蛋白/肌酐比值(UACR)心血管疾病臂-踝脉搏波传导速度(BaPWV)

Identifiers

PMID35510608
PMCPMC9366591
OpenAlexW4229009072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.